Sun Pharma and Philogen sign global licensing agreement for Fibromun
Agreement focuses on global commercialisation of anti-cancer immunotherapy
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
European Medicines Agency
What effect does X-ray inspection have on pharma products?
Pharma manufacturers continue to have concerns over the effect that X-ray inspection could have on their medicines. Are they right…
Dr Reddy’s receives positive CHMP opinion for biosimilar Rituximab candidate in European markets
Dr Reddy's Rituximab biosimilar DRL_RI (ITUXREDI) progresses towards European approval with EMA CHMP endorsement
Submission of Nidlegy marketing authorisation application validated by EMA
The first marketing authorisation application of Nidlegy for the treatment of locally advanced fully resectable melanoma was…
EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD: GlobalData
Dupixent shows promise for COPD, new treatment option reduces flare - ups and improves breathing
AstraZeneca’s COVID prevention drug application gets EU fast-track assessment
An accelerated assessment aims to speed up the European Medicines Agency’s (EMA) review of a market authorisation application
EMA approves Biocon’s new mAbs facility in India
EMA also renews GMP certifications for Biocon’s India and Malaysia sites
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…
Biocon Biologics gets EC approval for YESAFILI, biosimilar Aflibercept
The EC decision follows the European Medicines Agency’s CHMP positive opinion recommending approval of YESAFILI in July
Biocon Biologics gets positive CHMP opinion for YESAFILI, biosimilar Aflibercept
YESAFILI is intended for the treatment of neovascular age-related macular degeneration, visual impairment due to macular oedema…